Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats
- PMID: 21531393
- PMCID: PMC3150294
- DOI: 10.1016/j.biopsych.2011.03.017
Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats
Abstract
Background: The kappa opioid receptor (KOR) system contributes to the prodepressive and aversive consequences of stress and is implicated in the facilitation of conditioned fear and anxiety in rodents. Here, we sought to identify neural circuits that mediate KOR system effects on fear and anxiety in rats.
Methods: We assessed whether fear conditioning induces plasticity in KOR or dynorphin (the endogenous KOR ligand) messenger RNA (mRNA) expression in the basolateral (BLA) and central (CeA) nuclei of the amygdala, hippocampus, or striatum. We then assessed whether microinfusions of the KOR antagonist JDTic (0-10 μg/side) into the BLA or CeA affect the expression of conditioned fear or anxiety. Finally, we examined whether fear extinction induces plasticity in KOR mRNA expression that relates to the quality of fear extinction.
Results: Fear conditioning upregulated KOR mRNA in the BLA by 65% and downregulated it in the striatum by 22%, without affecting KOR levels in the CeA or hippocampus, or dynorphin levels in any region. KOR antagonism in either the BLA or CeA decreased conditioned fear in the fear-potentiated startle paradigm, whereas KOR antagonism in the BLA, but not the CeA, produced anxiolytic-like effects in the elevated plus maze. Effective fear extinction was associated with a 67% reduction in KOR mRNA in the BLA.
Conclusions: These findings suggest that fear conditioning and extinction dynamically regulate KOR expression in the BLA and provide evidence that the BLA and CeA are important neural substrates mediating the anxiolytic-like effects of KOR antagonists in models of fear and anxiety.
Copyright © 2011 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior.PLoS One. 2009 Dec 31;4(12):e8528. doi: 10.1371/journal.pone.0008528. PLoS One. 2009. PMID: 20052275 Free PMC article.
-
Short-term adaptation of conditioned fear responses through endocannabinoid signaling in the central amygdala.Neuropsychopharmacology. 2011 Feb;36(3):652-63. doi: 10.1038/npp.2010.196. Epub 2010 Oct 27. Neuropsychopharmacology. 2011. PMID: 20980994 Free PMC article.
-
Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.J Pharmacol Exp Ther. 2007 Dec;323(3):838-45. doi: 10.1124/jpet.107.127415. Epub 2007 Sep 6. J Pharmacol Exp Ther. 2007. PMID: 17823306
-
Dynorphin, stress, and depression.Brain Res. 2010 Feb 16;1314:56-73. doi: 10.1016/j.brainres.2009.09.074. Epub 2009 Sep 24. Brain Res. 2010. PMID: 19782055 Free PMC article. Review.
-
Pharmacological analysis of fear-potentiated startle.Braz J Med Biol Res. 1993 Mar;26(3):235-60. Braz J Med Biol Res. 1993. PMID: 8257926 Review.
Cited by
-
Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.J Neurosci. 2016 Sep 21;36(38):9937-48. doi: 10.1523/JNEUROSCI.0953-16.2016. J Neurosci. 2016. PMID: 27656031 Free PMC article.
-
Suicide Risk and Addiction: The Impact of Alcohol and Opioid Use Disorders.Curr Addict Rep. 2021;8(2):194-207. doi: 10.1007/s40429-021-00361-z. Epub 2021 Mar 14. Curr Addict Rep. 2021. PMID: 33747710 Free PMC article. Review.
-
Stress-induced activation of the dynorphin/κ-opioid receptor system in the amygdala potentiates nicotine conditioned place preference.J Neurosci. 2012 Jan 25;32(4):1488-95. doi: 10.1523/JNEUROSCI.2980-11.2012. J Neurosci. 2012. PMID: 22279233 Free PMC article.
-
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment.Prog Neuropsychopharmacol Biol Psychiatry. 2015 Oct 1;62:51-60. doi: 10.1016/j.pnpbp.2015.01.001. Epub 2015 Jan 12. Prog Neuropsychopharmacol Biol Psychiatry. 2015. PMID: 25592680 Free PMC article. Review.
-
Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues.Bioorg Med Chem Lett. 2012 Jan 15;22(2):1023-6. doi: 10.1016/j.bmcl.2011.11.128. Epub 2011 Dec 7. Bioorg Med Chem Lett. 2012. PMID: 22204910 Free PMC article.
References
-
- Pfeiffer A, Brantl V, Herz A, Emrich HM. Psychotomimesis mediated by kappa opiate receptors. Science. 1986;233:774–776. - PubMed
-
- Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther. 1993;264:489–495. - PubMed
-
- Carlezon WA, Jr, Beguin C, DiNieri JA, Baumann MH, Richards MR, Todtenkopf MS, et al. Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther. 2006;316:440–447. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- F31MH078473/MH/NIMH NIH HHS/United States
- R01MH063266/MH/NIMH NIH HHS/United States
- P50MH066172/MH/NIMH NIH HHS/United States
- F32DA026250/DA/NIDA NIH HHS/United States
- R01 DA009045/DA/NIDA NIH HHS/United States
- F32 DA026250/DA/NIDA NIH HHS/United States
- R01 MH074000-04/MH/NIMH NIH HHS/United States
- F31 MH078473/MH/NIMH NIH HHS/United States
- R01MH074000/MH/NIMH NIH HHS/United States
- R01 MH074000/MH/NIMH NIH HHS/United States
- R01 MH063266/MH/NIMH NIH HHS/United States
- R01DA009045/DA/NIDA NIH HHS/United States
- R01 MH063266-10/MH/NIMH NIH HHS/United States
- R01 MH074000-03/MH/NIMH NIH HHS/United States
